Heim4530 • TYO
add
Hisamitsu Pharmaceutical Co Inc
Við síðustu lokun
4.239,00 ¥
Dagbil
4.215,00 ¥ - 4.284,00 ¥
Árabil
3.600,00 ¥ - 4.700,00 ¥
Markaðsvirði
359,40 ma. JPY
Meðalmagn
157,27 þ.
V/H-hlutf.
21,62
A/V-hlutfall
2,03%
Aðalkauphöll
TYO
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(JPY) | ágú. 2024info | Breyting á/á |
---|---|---|
Tekjur | 39,65 ma. | 13,66% |
Rekstrarkostnaður | 18,75 ma. | 17,95% |
Nettótekjur | 4,31 ma. | -1,33% |
Hagnaðarhlutfall | 10,87 | -13,18% |
Hagnaður á hvern hlut | — | — |
EBITDA | 6,35 ma. | 20,49% |
Virkt skatthlutfall | 28,38% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(JPY) | ágú. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 122,74 ma. | -13,22% |
Heildareignir | 350,48 ma. | 1,79% |
Heildarskuldir | 74,55 ma. | 7,74% |
Eigið fé alls | 275,92 ma. | — |
Útistandandi hlutabréf | 73,34 m. | — |
Eiginfjárgengi | 1,14 | — |
Arðsemi eigna | 3,52% | — |
Ávöxtun eigin fjár | 4,46% | — |
Peningaflæði
Breyting á handbæru fé
(JPY) | ágú. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | 4,31 ma. | -1,33% |
Handbært fé frá rekstri | — | — |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | — | — |
Breyting á handbæru fé | — | — |
Frjálst peningaflæði | — | — |
Um
The Hisamitsu Pharmaceutical Co., Inc., headquartered in Saga and Tokyo, is a Japanese multinational pharmaceutical corporation that develops and markets prescription and over-the-counter drug products, especially external pain relieving products such as the transdermal patch. Hisamitsu has specialised in transdermal drug delivery system technology since the introduction of its original line of patches in 1903.
Hisamitsu's products under the Salonpas and Bye-Bye Fever brands are exported to over fifty countries. Hisamitsu also manufactures the Mohrus and Mohrus-Tape lines of external pain relief prescription products for the Japanese drug market. The company also manufactures internal medicines, eyedrops for general application, and the Lifecella Face Mask, a skincare product. Hisamitsu has developed the only over-the-counter transdermal patches approved by the U.S Food and Drug Administration. Wikipedia
Stofnsett
1847
Höfuðstöðvar
Vefsvæði
Starfsfólk
2.759